A prospective study on prognostic value of ventilatory efficiency in asymptomatic patients with severe primary mitral regurgitation
Johannes Bergsten, Tomasz Baron, Eva-Maria Hedin, Nermin Hadziosmanovic, Andrei Malinovschi, Frank A. Flachskampf

TL;DR
This study shows that measuring ventilatory efficiency during exercise can predict the need for surgery in patients with severe heart valve issues who have no symptoms.
Contribution
The study demonstrates that ventilatory efficiency during CPET is a novel independent predictor of mitral valve surgery in asymptomatic severe PMR patients.
Findings
Impaired ventilatory efficiency predicted surgical treatment in asymptomatic PMR patients.
The VE/VCO2 ratio at anaerobic threshold was an independent predictor after adjusting for other factors.
Ventilatory efficiency may serve as a new tool for risk stratification in PMR.
Abstract
Patients with severe primary mitral regurgitation (PMR) remain asymptomatic at first. In the long term, however, severe PMR leads to cardiac decompensation. Exercise testing in asymptomatic PMR is recommended in selected patients by guidelines. Cardiopulmonary exercise testing (CPET), which additionally measures ventilation (VE), oxygen consumption (VO2) and carbon dioxide production (VCO2), has been scarcely studied in PMR. We hypothesized that CPET might have prognostic value in asymptomatic PMR and therefore studied if CPET, including assessment of ventilation efficiency, has prognostic value for asymptomatic patients with severe PMR. Asymptomatic patients with severe PMR were prospectively recruited between 2013 and 2018. Exclusion criteria were coronary artery disease, chronic kidney disease, diabetes mellitus, concomitant valve disease, symptomatic lung disease or class 1…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiovascular Function and Risk Factors · Cardiac Valve Diseases and Treatments · Pulmonary Hypertension Research and Treatments
